Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
1
2
3
4
5
6
7
8
9
10
11
12
13
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
283
566
849
1132
1415
1698
1981
2264
2547
2830
Rituxan
(rituximab) / Roche
Keytruda
(pembrolizumab) / Merck (MSD)
Opdivo
(nivolumab) / BMS
AiRuiKa
(camrelizumab) / HLB Bio Group
Tecentriq
(atezolizumab) / Roche
Imfinzi
(durvalumab) / AstraZeneca
Tyvyt
(sintilimab) / Eli Lilly
Tevimbra
(tislelizumab-jsgr) / BeiGene
sunitinib
/ Generic mfg.
Loqtorzi
(toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Ibrance
(palbociclib) / Pfizer
Campath
(alemtuzumab) / Sanofi
Bavencio
(avelumab) / EMD Serono
Gazyva
(obinutuzumab) / Roche, Biogen
Orencia
(abatacept) / BMS
Darzalex
(daratumumab) / J&J
Ariely
(adebrelimab) / Jiangsu Hengrui Pharma
Verzenio
(abemaciclib) / Eli Lilly
Kaitanni
(cadonilimab) / Akesobio
Promacta
(eltrombopag) / Novartis
Adcetris
(brentuximab vedotin) / Takeda, Pfizer
Xalkori
(crizotinib) / Pfizer
Kisqali
(ribociclib) / Novartis
Libtayo
(cemiplimab-rwlc) / Regeneron
Truxima
(rituximab-abbs) / Indukern, Teva, Mundipharma, Celltrion, Nippon Kayaku
Blincyto
(blinatumomab) / Astellas, Amgen
Simulect
(basiliximab) / Novartis
Arzerra
(ofatumumab) / Novartis, Genmab
Mylotarg
(gemtuzumab ozogamicin) / Pfizer
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
Zevalin
(ibritumomab tiuxetan) / Servier, Aurobindo
Ocrevus
(ocrelizumab) / Roche
Darzalex Faspro
(daratumumab and hyaluronidase-fihj) / J&J
Hetronifly
(serplulimab) / Fosun Pharma
Enweida
(envafolimab) / 3DMed, Ascletis
Anniko
(penpulimab) / Akesobio, Sino Biopharm
Sarclisa
(isatuximab-irfc) / Sanofi
Jemperli
(dostarlimab-gxly) / GSK
Nplate
(romiplostim) / Amgen
Yutuo
(zimberelimab) / Arcus Biosci, Gilead
Zinbryta
(daclizumab) / Biogen, AbbVie
Nulojix
(belatacept) / BMS
Hengqu
(hetrombopag) / Jiangsu Hengrui Pharma
Polivy
(polatuzumab vedotin-piiq) / Roche
benmelstobart
(APL-502) / Apollomics
spartalizumab
(PDR001) / Novartis
Doptelet
(avatrombopag) / SOBI
Besponsa
(inotuzumab ozogamicin) / Pfizer, UCB
alvocidib
(DSP-2033) / Sumitomo Pharma
1
2
3
4
5
6
7
8
9
10
11
12
13
...
27
28
»
